4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-25-000015
Chief Scientific Officer acquired 28,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Mahaney Paige · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-14 | Grant or award : show line 1 in the form | +28,200 | 105,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-14 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +42,400 | 42,400 | D |
Loading xslF345X05/wk-form4_1739915672.xml…